SEC Form 4 · accession 0001104659-17-074064
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Troy Hamilton
Officer — CEO
Period of report
Dec 19, 2017
Accepted (ET)
Dec 19, 2017 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $2.01 | Dec 19, 2017 | A | 1,000,000 | A | — | Dec 19, 2027 | Common Stock | 1,000,000 | 1,675,000 | D |
Explanation of responses
- F1333,000 of the stock options vest on 12/19/2018 and 2019 and 334,000 vest on 12/19/2020.